Ligand Pharmaceuticals
LGND
#4127
Rank
$2.21 B
Marketcap
$121.25
Share price
-6.66%
Change (1 day)
118.94%
Change (1 year)

P/S ratio for Ligand Pharmaceuticals (LGND)

P/S ratio as of November 2024 (TTM): 16.6

According to Ligand Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.86. At the end of 2024 the company had a P/S ratio of 11.3.

P/S ratio history for Ligand Pharmaceuticals from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202411.319.58%
20239.4845.3%
20226.53-29.93%
20219.318.57%
20208.58-41.18%
201914.630.16%
201811.2-45.29%
201720.55.1%
201619.5-35.21%
201530.186.35%
201416.1-26.59%
201322.056.36%
201214.180.84%
20117.775.16%
20107.3913.73%
20096.50-31.74%
20089.52-73.03%
200735.3142.56%
200614.6192.86%
20054.97-7.18%
20045.36-29.68%
20037.6291.88%
20023.97-71.82%
200114.1

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
5.37-67.62%๐Ÿ‡บ๐Ÿ‡ธ USA
8.22-50.49%๐Ÿ‡บ๐Ÿ‡ธ USA
1.84-88.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
4.17-74.89%๐Ÿ‡บ๐Ÿ‡ธ USA
2.72-83.60%๐Ÿ‡บ๐Ÿ‡ธ USA
19.3 16.41%๐Ÿ‡บ๐Ÿ‡ธ USA
2.31-86.05%๐Ÿ‡บ๐Ÿ‡ธ USA
1.18-92.90%๐Ÿ‡บ๐Ÿ‡ธ USA
4.27-74.28%๐Ÿ‡บ๐Ÿ‡ธ USA